Q-omics provides the consensus-scored RPS7P3 profile across patient tissues and cancer cell-line models. RPS7P3 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, RPS7P3 is differentially expressed in 16, with the highest sampling consensus in HNSC. Additionally, RPS7P3 RNA expression shows 14,450 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight KIRC, HNSC, and LSCC as cancer lineages where RPS7P3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RPS7P3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RPS7P3 survival associations across molecular data types. RPS7P3 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RPS7P3 RNA expression–survival associations across cancer types. High RPS7P3 expression shows unfavorable associations in KIRC, KIRP, LIHC, MESO, ACC and ESCA. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRC as the clearest survival context for RPS7P3 RNA expression.
This table summarizes RPS7P3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 16. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for RPS7P3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RPS7P3 shows higher tumor expression in HNSC, BLCA, COAD, LIHC, KIRC and LUSC. The HNSC box plot shows higher RPS7P3 RNA expression in tumor versus normal tissue (log2 FC = +0.405, t-test p < 0.001).
This table shows molecular features associated with RPS7P3 in patient tissues and cancer cell lines. In patient samples, RPS7P3 shows the broadest associations at the RNA and protein expression levels, with LSCC recurring as the lineage with the largest associated feature set.
